Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis

Background: Sexual function is impaired in women with inflammatory bowel disease (IBD) as compared to normal controls. We examined disease specific determinants of different aspects of low sexual function.

Women with IBD aged 18 to 65 presenting to the university departments of internal medicine and surgery were includ ed. In addition, a random sample from the national patients organization was used (separate analyses). Sexual function was assessed by the Brief Index of Sexual Function in Women, comprising seven different domains of se xuality. Function was considered impaired if subscores were < -1 on a z-normalized scale. Results are presented as age adjusted odds ratios with 95% CI based on multiple logistic regression.

336 questionnaires were includ ed (219 Crohn's di sease, 117 ulcerative colitis). Most women reported low sexual activity (63%; 17% none at all, 20% moderate or high activity). Partnership satisfaction was high in spite of low sexual interest in this group. Depressed mood was the strongest predictor of low se xual function scores in all domains. Urban residency and higher socioecomic status had a protecti ve effect. Disease activity was mo derately associated with low desire (OR 1.8, 95% CI 1.0 to 3.2). Severity of the disease cour se impacted most on intercourse frequency (OR 2.3, 95% CI 1.4 to 4.7). Lubrication problems were more common in smokers (OR 2.5, 95% CI 1.3 to 5.1).

Mood disturbances and social environmen t impacted more on sexual function in women with IBD than disease specific factors. Smoking is associated with lubrication problems.

Ulcerative colitis and Crohn's disease typically affect ado- lescents or young adults and are characterized by a chron- ically remitting course. Many symptoms, complications and consequences of these diseases are likely to impact on body image, intimacy and sexual function [1]. Fatigue, Published: 3 October 2008 BMC Gastroenterology 2008, 8:45 doi:10.1186/1471-230X-8-45 Received: 18 December 2007 Accepted: 3 October 2008 This article is available from: http://www.biomedcentral.com/1471-230X/8/45 © 2008 Timmer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Gastroenterology 2008, 8:45 http://www.biomedcent ral.com/1471-230X/8/45 Page 2 of 10 (page number not for citation purposes) pain and diarrhoe are typical features of relapse and may further be aggravated by the embarrassing features of incontinence and bad odours. Perianal disease affects about one third of patients with Crohn's disease. Many will require surgery, possibly including the installation of a permanent or, more often, transient ostomy. Malnutri- tion or medical therapy with corticosteroids may also be associated with changes in the bodily appearance. Fur- thermore, mood disorders, in particular depression, are reported to be common in IBD [2]. Mood disorders are, at the same time, known to constitute a major risk factor for decreased sexual function [3]. It was therefore not surprising, when, almost 15 years ago, Moody and Mayberry described significantly decreased sexual activity in women with Crohn's disease, based on structured interviews in 50 women with friend controls [4]. Twenty-four percent of the cases abstained from sex- ual activities altogether due to the disease (controls: 4%). Moody and Mayberry complemented this study by another survey including 50 women with ulcerative colitis [5]. Since then, there has been very little research on this issue as recently reviewed [6,7]. The few studies available mostly focused on postoperative outcomes, as abdominal surgery has the potential for structural changes or pelvic nerve damage [8-10]. Many other issues concerning sexual health in women with IBD remain unclear. We have recently conducted a case control survey in mem- bers of the German IBD patients organization [11]. These persons form a relatively healthy group of IBD patients. Even so, all aspects of female sexuality covered by a sensi- tive validated instrument [12] were impaired in the IBD cases, as compared to controls. In contrast to the results in men, impaired function in women did not depend on the activity of the disease but was also manifest in remission. Due to the case-control design and the use of ambulatory patients only, this previous survey offered little informa- tion on disease specific risk factors. To shed more light on the disease related determinants of sexual function in women with IBD, we have now con- ducted a survey in a well described clinical sample of patients. Here, we present data from both surveys.

Participants Consecutive patients with IBD, aged 18 to 65, were included on presentation to the university hospital departments of internal medicine and surgery. Patients with major acute or chronic co-morbidity, unrelated to IBD, were excluded if interference with quality of life and sexuality in particular was considered likely. This was left to the discretion of the treating physician. The list of examples for exclusion included the following: chronic – advanced cancer, complicated diabetes, neurological dis- ease compromising mobility (such as stroke or multiple sclerosis), remitting cardiac failure; acute – recent surgery for any condition other than IBD, all patients currently in or recently transferred from intensive care. Outpatients were also recruited. The response rate was calculated as the proportion of contacted persons returning a com- pleted questionnaire. This clinical group was complemented by cases from the national patient organization (German Crohn's and Coli- tis Association/Deutsche Crohn und Colitis Vereinigung, DCCV e.V.). These had been selected randomly from the members' list stratified by type of disease [11]. Questionnaire Questionnaires were identical for the two groups (clinical group and national patient organization) with respect to the assessment of exposures and sexual function. For clin- ical patients additional modules on disease specific qual- ity of life were included (Short Inflammatory Bowel Disease Questionnaire (S-IBDQ) [13], QLQ CR 38 mod- ule of the European Organization for Research and Treat- ment of Cancer (EORTC) [14]. Information on sociodemographic data, life style factors, co-morbidity, and co-medication was collected using a questionnaire module developed by the German IBD Competence Network for use in IBD patients. Life style factors included sports, smoking and alcohol consump- tion. Socioeconomic status (SES) was calculated as a com- posite measure based on income, education and professional status, as suggested by the German Epidemi- ological Association, DGEpi [15], and were summarized as low, middle, and high. Specific questions related to the presence of diabetes and hypertension. Other co-morbidities and co-medications were evaluated based on open questions. Diseases (such as cardiovascular, hepatobiliary) and medications (such as antihypertensive, antidepressant, other psychiatric) were coded, grouped and used for a summary co-morbid- ity measure: minor: one disease OR one medication; major: a) at least one disease AND at least one medication or b) more than one disease or medication. The disease activity was classified as remission/low activ- ity vs. moderate/high activity. The cut points were set at 220 for Crohn's disease on a modified Crohn's Disease Activity Index for use in surveys (S-CDAI), and 5 for ulcerative colitis on the Clinical Activity Index survey ver- sion (S-CAI). This instrument was previously validated [16]. Disease course (severity) was graded as mild (less than one relapse per year), medium (1 or 2 relapses per year) and severe (frequent relapses or persistent prob- BMC Gastroenterology 2008, 8:45 http://www.biomedcent ral.com/1471-230X/8/45 Page 3 of 10 (page number not for citation purposes) lems). Psychological functioning was assessed with the Hospital Anxiety and Depression Scale (HADS) [17,18]. Persons were considered depressed or anxious if the respective HADS-Subscore exceeded 10. Assessment of sexual function As there was no validated questionnaire on female sexual dysfunction available for the use in German language, the Brief Index of Sexual Function in Women (BISF-W) was transformed for use in German [12,19]. Formal cultural adaptation methods were used as described for other quality of life instruments [20]. This included independ- ent translation of the questionnaire by two native speak- ers of German and back-translation into English by a native speaker of English. Further minor modifications of the layout and wording were applied following a pilot study in 60 persons (patients with and without IBD, healthy volunteers) to improve understandibility and ease of use. The questionnaire then underwent formal valida- tion assessments, including test-retest reliability, internal concistency, construct validity and sensitivity for change [21]. Overall, the BISF-W showed excellent test properties for all domains but the subscore of specific sexual problems, which lacked internal consistency. This domain combines several, mainly somatic problems occuring with sexual intercourse in women, such as vaginismus, bleeding or headaches after intercourse. For subscores and the total score, higher values denote better function with the exception of the specific sexual problems (higher score = more problems). The scores were calculated and transformed as suggested in the key-publi- cation by Mazer [12]. Due to a layout problem in the questionnaire, one of two items pertaining to the arousal domain was incorrectly or not at all answered by the majority of patients. Arousal scores will therefore be omit- ted from the subscore presentation in this paper due to limited interpretability. Tests on correctly completed questionnaires showed that total scores were reliably esti- mated without the missing item (correlation coefficient: r = 0.99).

from a healthy German control group were used as a standard population (friend controls from our matched case control study). Due to a negative correlation with age (in particular, for the subscores of intercourse frequency and thoughts and desires), standardization was stratified by age. Z-transformation results in a score where 0 repre- sents the standard population mean, and 1 the standard deviation. Low sexual function in any of the domains was defined as a score < -1, representing a score lower than one standard deviation from the mean score of the normative sample. The EORTC module for colorectal cancer patients was chosen as it contains several direct questions on body image, sexual function and satisfaction and ostomy func- tion [14]. It generally applies four answer categories, which were collapsed into two and presented as the pro- portion of those answering definitely or rather positive (vs. definitely or rather negative) for simplified graphical display. Although previously used in IBD patients [22], the instrument has not been developed and validated for this purpose. Therefore, summary scores will not be pre- sented. Statistical analyses For exploratory analyses graphical displays (means with 95% confidence intervals (95% CI)) are used. In addition, the frequency of low scores is reported separately for both study groups for descriptive purposes. As crude rates are not comparable between women with and without part- ners these figures are presented for women with partners only. However, all women were included in the main analyses. Multivariate logistic regression was applied to calculate adjusted odds ratios (OR) with 95% CI (SPSS ©) [23]. Increased ratios (OR > 1.0) denote an increased risk for low function in participants positive for the respective risk factor. In the multivariate analyses, full models were ini- tially calculated, including all potential risk factors, fol- lowed by manual stepwise elimination based on model fit, and the robustness and the statistical significance of the estimated coefficients. All models were adjusted for age and having a partner. Ethical considerations The study was approved by the ethics committee of the institution (02/163). The steering board of the patients' organization also approved of the protocol, question- naires and information material. Clinical patients pro- vided written consent. Patient organization members consented by returning a completed questionnaire based on written information.

Participants Clinical patient recruitment took place from September 1, 2003 through October 31, 2005. 119 eligible women were approached, 107 agreed to participate (90%). Of these, 95 returned a completed questionnaire (clinical sample response rate 81%). No patient related characteristics were found to be associated with response in this sample. In addition, nineteen questionnaires from the outpatient department were received. For this group, a response rate could not be calculated as recruitment had to be paused BMC Gastroenterology 2008, 8:45 http://www.biomedcent ral.com/1471-230X/8/45 Page 4 of 10 (page number not for citation purposes) repeatedly due to interference with competing clinical tri- als (unknown denominator). Of the patient organization member survey, 222 ques- tionnaires were available for analysis (500 women selected; response rate 44%). In this sample, the response rate was higher in younger women (< 30 years of age: 58%). The combined sample comprised 336 women. 219 of these (65%) had Crohn's disease, 117 ulcerative colitis. The sociodemographic and other characteristics by dis- ease type and patient group are shown in Table 1. Patients in the clinical group were younger. The regional East- Bavarian catchment area of the university hospital is reflected by high proportions of rural residency and catholicism. Clinical patients were also more often depressed and more often smokers. As expected, smoking status was dependent on the type of disease (less smokers in ulcerative colitis). The comparison of the disease specific characteristics revealed the expected higher proportion of patients with severe or active disease and those on steroids in the clini- cal group (Table 2). Long term immunosuppression, on the other hand, was more common in the DCCV group, which was also characterized by a longer disease duration and higher percentage of past resecting surgery. Sexual function – explorative analyses In Figure 1, mean z-values for BISF-W subscores and the total score are shown by study group with 95% CI, restricted to women with partners for better comparabil- ity. Case scores were consistently lower (or higher for spe- cific problems ) than 0 (representing the standard population mean), but all deviations were minor (within one standard deviation). For most subscores, patient organization members scored slightly better than clinical cases with the notable exception of partnership satisfac- tion. Differences between the groups were not statistically significant for any of the subscores. On direct questioning (EORTC-items), issues relating to feeling attractive or feminine as well as satisfaction with the bodily appearance showed an association with disease activity (p < 0.05 for all comparisons) (Figure 2, informa- tion available for clinical sample only). There was a strik- ingly low general interest in sexual activities in both patients with active and quiescent disease. Only 20% reported a high or moderate level of sexual activity during the preceding four weeks. The proportion not sexually active at all was 17%. Determinants of impaired sexual function Adjusted odds ratios from multivariate analyses are pre- sented in Table 3 for selected variables. There was no evi- dence for differences between patients with Crohn's disease and patients with ulcerative colitis. Depressive Table 1: Participants' characteristics – demographics and other general information Group A – clinical Group B – DCCV Crohn's disease Ulcerative colitis Crohn's disease Ulcerative colitis Age (median) 38.5 yrs 38.0 yrs 38.0 yrs 38.0 yrs Working fulltime 32 (36%) 5 (21%) 40 (31%) 31 (33%) In training/at school 5 (6%) 1 (4%) 10 (8%) 5 (5%) SES high 8 (10%) 4 (20%) 48 (39%) 35 (40%) SES low 31 (38%) 5 (25%) 13 (11%) 3 (3%) Urban residency 13 (15%) 5 (21%) 51 (40%) 36 (39%) Smokers 46 (52%) 6 (25%) 38 (30%) 6 (7%) Roman catholic 74 (82%) 15 (63%) 35 (27%) 27 (29%) Protestant/Lutheran 9 (10%) 5 (21%) 55 (43%) 33 (36%) Comorbidity, minor 19 (21%) 4 (3%) 20 (16%) 14 (15%) Comorbidity, major 22 (24%) 5 (21%) 31 (24%) 24 (26%) Diabetes 5 (6%) 6 (3%) 1 (1%) 2 (2%) Antihypertensive Therapy 7 (8%) 4 (17%) 7 (5%) 5 (5%) On hormonal contraception 25 (28%) 6 (25%) 29 (22%) 24 (26%) On hormone replacement 3 (3%) 1 (4%) 5 (4%) 4 (3%) Anxiety 33 (37%) 7 (30%) 38 (30%) 20 (22%) Depression 19 (21%) 8 (35%) 12 (10%) 9 (10%) Has a partner 61 (69%) 18 (78%) 93 (74%) 74 (80%) Married 41 (46%) 16 (67%) 65 (51%) 53 (57%) N9 0 2 4 1 2 9 9 3 Not all categories shown for most variables. BMC Gastroenterology 2008, 8:45 http://www.biomedcent ral.com/1471-230X/8/45 Page 5 of 10 (page number not for citation purposes) mood was the only consistent risk factor, with strong asso- ciations for all subscores. Anxiety seemed to be of impor- tance for the domain of intercourse frequency only. For other characteristics, associations were sparse. The multivariate analysis confirmed the difference in part- nership satisfaction between clinical and DCCV cases: women in the clinical group were less often dissatisfied, even after adjustment for SES, disease activity, depression, age and partnership status (OR 0.6; 95% CI 0.3 to 1.0). Otherwise, there was no evidence for systematic differ- ences between the two groups. Also, there was not differ- ence between women with Crohn's disease and women with ulcerative colitis. Disease activity contributed to the prediction of a low thoughts & desire score (OR 1.8; 95% CI 1.0 to 3.2). The disease course (severity) was more consistently predictive with OR > 1.0 for all subscores and a strong positive asso- ciation with intercourse frequency (OR 2.3). Current use of steroids was associated with low pleasure & orgasm scores. For the presence of an ostomy or current perianal disease, associations were not detected for any of the subscores. The direction of the results for these factors was inconsist- ent, rendering a relevant effect unlikely. Confidence inter- vals for effects of these infrequent situations were too wide to provide conclusive evidence. In contrast, a marked differential effect was found for high SES, which was protective of low thoughts & desire , but a risk factor for low partnership satisfaction. Urban residency showed consistently low odds ratios with strong negative associations for initiative & receptivity and pleasure & orgasm. Specific lifestyle factors (smoking, sports, alcohol) did not show conclusive associations with any of the sub- scores. Specific sexual problems As the subscore of specific sexual problems performed poorly as an aggregate measure in the validation assess- ment (see methods), analyses for this domain were based on answers to single items. Insufficient lubrication was reported to occur at least occasionally in 30% of the par- ticipants who had a sexual relationship. Current smoking was identified as a strong (and only) predictor of this problem (OR 2.5, 95% CI 1.3 to 5.1). Pain during inter- course was also quite common (25%), followed in preva- lence by vaginal infections (9%) and vaginismusus (8%). Predictors for any of these complaints were not identified. In particular there was no difference by disease type or activity, use of steroids, co-morbidity or presence of peri- anal disease. Incontinence of urine during intercourse (n = 5, 2%), headaches following sexual activity (n = 5; 2%) and postcoital bleeding (n = 12; 5%) were considered too Table 2: Participants' characteristics – disease related information (self reported) Group A – clinical Group B – DCCV Crohn's disease Ulcerative colitis Cr ohn's disease Ulcerative colitis Disease duration (median) 9.0 yrs 6.0 yrs 13.0 yrs 9.0 yrs Disease onset > 40 yrs 14 (16%) 3 (13%) 7 (6%) 6 (7%) Disease onset < 18 yrs 16 (18%) 3 (13%) 28 (22%) 15 (17%) Active disease 38 (42%) 19 (80%) 28 (22%) 31 (35%) Mild disease course 22 (26%) 5 (23%) 44 (36%) 32 (37%) Severe disease course 35 (42%) 7 (32%) 45 (37%) 21 (24%) Past resecting surgery 38 (42%) 1 (4%) 73 (57%) 10 (11%) Ostomy 10 (11%) 1 (4%) 13 (10%) 4 (5%) Ileocecal resection 27 (30%) 48 (37%) Perianal disease, current 19 (22%) 26 (21%) Perianal disease, ever 23 (27%) 36 (28%) Currently on steroids 39 (44%) 11 (48%) 35 (28%) 25 (28%) Other immunosuppression 18 (20%) 6 (25%) 43 (34%) 19 (21%) Total/substantial Colitis 14 (64%) 44 (49%) Left sided colitis 5 (23%) 29 (33%) Proctitis only 3 (14%) 16 (18%) Small bowel only 14 (19%) 25 (20%) Large bowel only 14 (19%) 37 (29%) Combined disease 41 (56%) 61 (48%) Upper Gi Involvement 4 (5%) 5 (4%) N9 0 2 4 1 2 9 9 3 Not all categories shown for most variables, missing values not reported BMC Gastroenterology 2008, 8:45 http://www.biomedcent ral.com/1471-230X/8/45 Page 6 of 10 (page number not for citation purposes) infrequent for meaningful further exploration or multi- variate analysis. The extent to which the disease was perceived to have had a negative influence on sexual activities over the last four weeks is displayed relative to other common distractors in Figure 3.

This study was designed to examine disease specific deter- minants of impaired sexual function in women. The com- bination of two different case groups enabled us to examine both patients in their normal living environment as well as those patients typically encountered by the uni- versity specialist, representing a wide array of clinical problems. No particular feature of IBD was identified that would explain the predescribed high prevalence of sexual imped- iments in women suffering from this chronic disease. Rather, the significance of psychosocial factors for female sexuality, well known from studies in normal popula- tions, was further underlined [24,25]. Foremost, depressed mood was confirmed as the strongest and most consistent risk factor. With the exception of specific sexual problems, depression impacted on all aspects of sexuality as assessed by the BISF-W. Anxiety seemed less important but may play a role in certain aspects of sexuality ( inter- course frequency). Urban residency was protective for sev- eral problems while the impact of socioeconomic status varied by subscore: Women with a higher socioeconomic status had higher scores for pleasure & orgasm, but scored worse on partnership satisfaction. This subscore was also unique in that it was the only score that differed between the two study groups The clinical patients were characterized by a higher than average level of partnership satisfaction. This phenomenon was underlined by several free-text comments such as "the disease has brought us closer together". Several women expressed gratefulness for their understanding partners who did not let them down in the difficult times of the disease. The importance of an understanding social envi- ronment, including the partner, for coping with IBD has been repeatedly observed in studies using analytic inter- views, foremost in the context of adjustment to an ostomy [26]. It is unclear why this effect was different in the two groups in spite of control for potential confounders of relation- ship appreciation. As the DCCV sample suffered from a rather low response rate, responder bias may have caused this observation. Possibly, for some reason, women in unsatisfactory relationships were more likely to respond. BISF-W scores (z-values) by case group, women with partners onlyFigure 1 BISF-W scores (z-values) by case group, women with partners only. 0: standard population mean, +/- 1 = +/- 1 stand- ard deviation from standard population mean. *specific problems: higher value = more problems, other scores: higher value = better function. BMC Gastroenterology 2008, 8:45 http://www.biomedcent ral.com/1471-230X/8/45 Page 7 of 10 (page number not for citation purposes) Alternatively, it is conceivable that partnership apprecia- tion in stressful situations is regionally different due to cultural factors beyond those assessed (rural residency, confession of faith, SES), or is different in persons joining self help organizations. The most striking finding in our survey might be the very low levels of sexual interest and activity. A high prevalence of low sexual desire is known from surveys in healthy populations [24,27]. Although low desire is acknowl- edged as a disease entity in the Diagnostic and Statistical Table 3: Determinants of low sexual function Thoughts & Desire Intercourse frequency Initiative & receptivity Pleasure & orgasm Partnership Satisfaction BISF-W – Total Score Clinical vs. DCCV case 1.4 (0.8 to 2.4) 1.3 (0.6 to 2.8) 1.3 (0.7 to 2.2) 1.5 (0.9 to 2.6) 0.6 (0.3 to 1.0) 0.9 (0.5 to 1.5) Ulcerative colitis vs. Crohn's disease 1.3 (0.7 to 2.1) 1.4 (0.8 to 2.7) 1.3 (0.8 to 2.3) 1.3 (0.8 to 2.2) 1.1 (0.7 to 1.9) 1.3 (0.8 to 2.2) Ostomy 0.8 (0.3 to 2.1) 1.2 (0.5 to 3.0) 1.5 (0.6 to 3.7) 0.5 (0.2 to 1.3) 0.9 (0.4 to 2.0) 0.7 (0.3 to 1.8) Current perianal disease 0.8 (0.4 to 1.7) 1.6 (0.8 to 3.1) 0.7 (0.3 to 1.6) 0.8 (0.4 to 1.7) 1.7 (0.8 to 3.5) 1.0 (0.5 to 2.0) Active disease 1.8 (1.0 to 3.2) 1.7 (0.9 to 3.1) 1.5 (0.8 to 2.7) 1.2 (0.7 to 2.1) 0.9 (0.5 to 1.6) 0.9 (0.5 to 1.6) Frequent relapses 1.2 (0.6 to 2.3) 2.3 (1.4 to 4.7) 1.6 (0.8 to 3.1) 1.8 (0.9 to 3.5) 1.2 (0.7 to 2.3) 1.3 (0.7 to 2.4) Disease duration > 10 yrs 0.7 (0.3 to 1.7) 0.6 (0.3 to 1.5) 0.9 (0.4 to 2.1) 0.6 (0.3 to 1.2) 1.2 (0.5 to 2.6) 0.8 (0.4 to 1.7) Current steroids 1.0 (0.6 to 1.7) 1.9 (1.1 to 3.3) 1.2 (0.7 to 2.0) 2.5 (1.5 to 4.4) 1.2 (0.7 to 1.9) 1.0 (0.6 to 1.7) Urban residency 0.8 (0.4 to 1.5) 0.8 (0.4 to 1.4) 0.4 (0.2 to 0.8) 0.5 (0.3 to 0.9) 0.9 (0.5 to 1.6) 0.6 (0.3 to 1.0) High SES 0.4 (0.2 to 0.8) 0.6 (0.2 to 1.3) 0.8 (0.3 to 2.0) 1.5 (0.8 to 2.8) 2.4 (1.0 to 5.5) 0.8 (0.3 to 1.7) Co-morbidity (major) 1.4 (0.7 to 2.6) 1.9 (1.0 to 3.5) 1.1 (0.5 to 2.0) 1.5 (0.8 to 2.8) 1.8 (1.0 to 3.2) 1.3 (0.7 to 2.4) Depression 2.9 (1.5 to 5.7) 3.5 (1.6 to 7.9) 4.4 (2.1 to 9.1) 4. 8 (2.2 to 10.1) 2.7 (1.4 to 5.4) 3.4 (1.4 to 6.9) Anxiety 1.6 (0.9 to 2.7) 2.0 (1.1 to 3.6) 1.4 (0.8 to 3.9) 1.7 (1.0 to 3.0) 1.5 (0.8 to 2.6) 1.4 (0.8 to 2.3) All odds ratios (95% CI) controlled for age, partnership status and determinants significantly contributing to the respective model; n = 336 or less. Strong associations in bold font (OR > 2.0; OR < 0.5)

from EORTC-QLQ CR30 items, clinical sample only (n = 114)Figure 2

from EORTC-QLQ CR30 items, clinical sample only (n = 114). Proportions of those answering "very"/"mod- erate" (vs. "little"/"not at all"). BMC Gastroenterology 2008, 8:45 http://www.biomedcent ral.com/1471-230X/8/45 Page 8 of 10 (page number not for citation purposes) Manual of Mental Disorders (DSM IV – R), it remains con- troversial whether it constitutes a sexual disorder [28,29]. For example, in women with chronic disease, loss of desire might be considered a physiological response to pain, fatigue or psychological distress. We do not wish to imply that all women with low scores consider themselves deficient or should receive treatment. It was unfortunate that we were not able to calculate arousal subscores for the majority of participants, as some might suspect arousal to be particularly sensitive to struc- tural changes or inflammatory processes in the perivagi- nal and pelvic region. The BISF-W arousal domain focuses on the subjective perception of sexual arousal which has been shown to poorly correlate with the physiological responses characterized by genital vasocongestion and lubrication [30]. We were able to assess predictors of lubrication as a somatic aspect of arousal and found a strong association with smoking. Confounding by this known risk factor of Crohn's disease should therefore be considered when vaginal dryness in Crohn's disease is reported. We are not aware of any data explaining this effect of smoking on the vaginal mucosa and would wel- come any discussion on this issue. There were no disease specific determinants. In particular, there was no epidemi- ological evidence for a causative effect of immunosup- pression, disease activity, or perianal disease in the pathogenesis of this or any of the other more common specific sexual problems. Our findings in women were quite different from our pre- vious observations in men [31]. Erectile function was mainly effected by somatic problems, while mood had more impact on issues of satisfaction. A similarly clear cut differentiation between the somatic and psychosocial aspects of sexuality was not possible in women. This may be innate to the more complex sequence of sexual behav- ior in women [28]. In addition, our results confirm previ- ously reported observations that women perceive the impact of the disease on sexuality and partnership differ- ently [32].

In summary, while low sexual function is common in women with IBD, no specific disease related characteris- tics were identified. Rather, as in women without chronic disease, psychosocial factors play a predominant role. While our data provide some basis for patient counsel- ling, the existence and relevance of sexual problems and any need for therapy should be determined individually in sympathetic patient-doctor interviews, if the patient wishes to do so. Often, treatment of mood disorders might be more important than specific sexual therapy. With respect to the most common specific sexual prob- lem, insufficient lubrication, our study provides yet Frequency with which different problems were felt to have impacted negatively on sexual activities (women with partners onlyFigure 3 Frequency with which different problems were felt to have impacted negatively on sexual activities (women with partners only). BMC Gastroenterology 2008, 8:45 http://www.biomedcent ral.com/1471-230X/8/45 Page 9 of 10 (page number not for citation purposes) another reason to advice patients with Crohn's disease against smoking. Abbreviations BISF-W: Brief Index of Sexual Function in Women, CAI: Colitis Activity Index; CDAI: Crohn's Disease Activity Index; EORTC: European Organization for Research and Treatment of Cancer; HADS: Hospital Anxiety and Depression Scale; IBD: Inflammatory bowel disease; QLQ – CR: Quality of Life, Colorectal Cancer; S-CAI: Survey based Colitis Activity Index; S-CDAI: Survey based Crohn's Disease Activity Index; S-IBDQ: Short Inflamma- tory Bowel Disease Questionnaire. Competing interests The authors declare that they have no competing interests. Authors' contributions AT conceived and planned the study, developed the ques- tionnaire, recruited patients, did the analysis and wrote the manuscript. DK participated in the planning of the study, piloted instruments and recruited patients. AB organized the survey, recruited patients and did some analyses. AT organized clinical recruitment and was responsible for data management. CO participated in patient recruitment. AF participated in the planning of the study, the development of the questionnaire and data retrieval. All authors read and the final version of this manuscript.

U. Steder-Neukamm and A. Dignass for relevant input during the concep- tion phase; L. Bjerre for back-translation of the questionnaire; F. Klebl for help with patient recruitment in outpatient clinics; B. Bokhof for help with patient recruitment and data entry; B. Effenberger and M. Bauer for data entry; G. Rogler, K.-H. Jöckel, J. Schölmerich and M. Singer for support and helpful comments on the project. C Mavergames for language editing. Financial support:The German competence network inflammatory bowel disease (KNCED)/Federal Ministry of Education and Research (BMBF) funded personnel for epidemiological research in IBD. The positions of A. Bauer, D. Kemptner and A. Takses (authors) and B. Bokhof and B. Effen- berger (acknowledgements). were funded by this programme. The funding agency was not involved in the planning, conduct and publication of this project. Part of the patient organization cases (n = 181) were included in the publi- cation on a matched case control analysis [11].

1. Giese LA, Terrell L: Sexual health issues in inflammatory bowel disease. Gastroenterol Nurs 1996, 19:12-17. 2. Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ: Functional gas- trointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis 2006, 12:38-46. 3. Kennedy SH, Dickens SE, Eisfeld BS, Bagby RM: Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 1999, 56:201-208. 4. Moody G, Probert CS, Srivastava EM, Rhodes J, Mayberry JF: Sexual dysfunction amongst women with Crohn's disease: a hidden problem. Digestion 1992, 52:179-183. 5. Moody GA, Mayberry JF: Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion 1993, 54:256-260. 6. Trachter AB, Rogers AI, Leiblum SR: Inflammatory bowel disease in women: impact on relationship and sexual health. Inflamm Bowel Dis 2002, 8:413-421. 7. Dubinsky MC: Sexuality Issues in IBD. Pract Gastroenterol 2005, 24:55-65. 8. Oresland T, Palmblad S, Ellstrom M, Berndtsson I, Crona N, Hulten L: Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolec- tomy. Int J Colorectal Dis 1994, 9:77-81. 9 . B e r n d t s s o n I , O r e s l a n d T , H u l t e n L : Sexuality in patients with ulcerative colitis before and after restorative proctocolec- tomy: a prospective study. Scand J Gastroenterol 2004, 39:374-379. 10. Metcalf AM, Dozois RR, Kelly KA: Sexual function in women after proctocolectomy. Ann Surg 1986, 204:624-627. 11. Timmer A, Bauer A, Dignass A, Rogler G: Sexual function in per- sons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol 2007, 5:87-94. 12. Mazer NA, Leib lum SR, Rosen RC: The brief index of sexual func- tioning for women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal popula- tions. Menopause 2000, 7:350-63. 13. Rose M, Fliege H, Hildebrandt M, Korber J, Arck P, Dignass A, et al.: [Validation of the new German translation version of the "Short Inflammatory Bowe l Disease Questionnaire" (SIBDQ)]. Z Gastroenterol 2000, 38:277-286. 14. Sprangers MA, te Velde A, Aaronson NK: The construction and testing of the EORTC colorect al cancer-specific quality of life questionnaire module (QLQ-CR38). European Organiza- tion for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer 1999, 35:238-47. 15. Ahrens W, Bellach B-M, Jöckel K-H: [Measuring sociodemographic var- iables] München: MMW Medizinverlag; 1998. 16. Timmer A, Kemptner D, Taks es A, Fürst A, Jöckel K-H: A survey based index was validated for measuring disease activity in Crohn's disease. Journal of Clinical Epidemiology in press. 17. Herrmann C: International experien ces with the Hospital Anxiety and Depression Scale – a review of validation data and clinical results. J Psychosom Res 1997, 42:17-41. 18. Herrmann C, Buss U, Snaith RP: HADS-D Hospital Anxiety and Depression Scale – [German version. Test documentation and manual]. 1st edition. Bern: Hans Huber; 1995. 19. Strauss B, Heim D: [Standardized procedures in empirical sex- uality research. An overview]. Z Sexualforsch 1999, 12:187-236. 20. Bullinger M, Alonso J, Apolone G, Leplege A, Sullivan M, Wood-Dau- phinee S, et al. : Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. Inter- national Quality of Life Assessment. J Clin Epidemiol 1998, 51:913-923. 21. Timmer A: [Sexual function and partnership in persons with inflammatory bowel diseases. Habilitation thesis.]. University of Regensburg. Department of Internal Medicine.; 2006. 22. Willis S, Lorken M, Holzl F, Fackeldey V, Schumpelick V: [Functional

and quality of life af ter proctocolectomy and ileal J- pouch-anal anastomosis for ulcerative colitis]. Zentralbl Chir 2003, 128:663-668. 23. Greenland S: Regression methods for epidemiologic analysis. In Handbook of Epidemiology Edited by: Ahrens W, Pigeot I. Berlin: Springer; 2005:627-691. 24. Bancroft J, Loftus J, Long JS: Distress about sex: a national survey of women in heterose xual relationships. Arch Sex Behav 2003, 32:193-208. 25. Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA: Correlates of sexual function among multi-ethnic middle- aged women: results from the Study of Women's Health Across the Nation (SWAN). Menopause 2005, 12:385-398. 26. Burnham WR, Lennard-Jones JE, Brooke BN: Sexual problems among married ileostomists. Survey conducted by The Ileos- tomy Association of Great Britain and Ireland. Gut 1977, 18:673-7. Publish with BioMed Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral BMC Gastroenterology 2008, 8:45 http://www.biomedcent ral.com/1471-230X/8/45 Page 10 of 10 (page number not for citation purposes) 27. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, et al.: Sexual problems among women and men aged 40–80 y: prevalence and correlates identi fied in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005, 17:39-57. 28. Basson R: Women's sexual dysfunction: revised and expanded definitions. Can Med Ass J 2005, 172:1327-1333. 29. Bancroft J: The medicalization of female sexual dysfunction: the need for caution. Arch Sex Behav 2002, 31:451-455. 30. Basson R: Clinical practice. Sexual desire and arousal disor- ders in women. N Engl J Med 2006, 354:1497-1506. 31. Timmer A, Bauer A, Kemptner D, Furst A, Rogler G: Determinants of male sexual function in inflammatory bowel disease: a sur- vey-based cross-sectional analysis in 280 men. Inflamm Bowel Dis 2007, 13:1236-1243. 32. Maunder R, Toner B, de Rooy E, Moskovitz D: Influence of sex and disease on illness-related conc erns in inflammatory bowel disease. Can J Gastroenterol 1999, 13:728-732. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-230X/8/45/pre pub